A New Approach to the Development of Disease-Modifying Therapies for PD; Fighting Another Pandemic

Presidential Perspective

Register


C. Warren OlanowSpeaker:
C. Warren Olanow MD, FRCPC, FRCP (hon)
Clintrex Research Corp, Mount Sinai School of Medicine, New York City, New York, USA

Webinar Topic:
A New Approach to the Development of Disease-Modifying Therapies for PD; Fighting Another Pandemic


Webinar Description:
A disease modifying therapy for PD is the major unmet therapeutic need in this disorder. Despite the many promising targets and candidate therapies, many pharmaceutical companies are abandoning this field because of the development costs and regulatory uncertainties. The lecture describes a new approach that Dr. Olanow believes can overcome these problems.

Learning Objectives:

  1. Be familiar with obstacles to development of a putative disease modifying therapy for PD 
  2. Know the clinical designs that have been used to date to try and define a disease modifying therapy
  3. Appreciate a new approach to developing disease modifying therapies for PD

Target Audience:
Movement disorder specialists, neurologists, individuals in the biotech and pharmaceutical industry who are potentially interested in developing disease modifying therapies for PD

This lecture will be made available for on-demand viewing starting on February 3, 2021.

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice